The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dutasteride/Tamsulosin Rowa 0.5 mg/0.4 mg hard capsules.

Rowa Pharmaceuticals LimitedPA0074/076/001

Main Information

Trade NameDutasteride/Tamsulosin Rowa 0.5 mg/0.4 mg hard capsules.
Active SubstancesTamsulosin hydrochloride
Dosage FormCapsule, hard
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/076/001

Group Information

ATC CodeG04CA52 tamsulosin and dutasteride


License statusAuthorised
Licence Issued11/09/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0036-065-001
Interchangeable List DocumentPDF of Interchangeable List
« Back